155 related articles for article (PubMed ID: 29650051)
1. Proteolytic biomarkers are related to prognosis in COPD- report from a population-based cohort.
Linder R; Rönmark E; Pourazar J; Behndig AF; Blomberg A; Lindberg A
Respir Res; 2018 Apr; 19(1):64. PubMed ID: 29650051
[TBL] [Abstract][Full Text] [Related]
2. Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.
Linder R; Rönmark E; Pourazar J; Behndig A; Blomberg A; Lindberg A
Respir Res; 2015 Feb; 16(1):28. PubMed ID: 25849664
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity.
Uysal P; Uzun H
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781876
[TBL] [Abstract][Full Text] [Related]
4. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio for diagnosis and assessment of COPD severity.
Dimic-Janjic S; Hoda MA; Milenkovic B; Kotur-Stevuljevic J; Stjepanovic M; Gompelmann D; Jankovic J; Miljkovic M; Milin-Lazovic J; Djurdjevic N; Maric D; Milivojevic I; Popevic S
Eur J Med Res; 2023 Mar; 28(1):127. PubMed ID: 36935521
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients.
Hao W; Li M; Zhang C; Zhang Y; Wang P
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):224-230. PubMed ID: 31046512
[No Abstract] [Full Text] [Related]
8. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
Lo CY; Huang HY; He JR; Huang TT; Heh CC; Sheng TF; Chung KF; Kuo HP; Wang CH
Int J Chron Obstruct Pulmon Dis; 2018; 13():1135-1144. PubMed ID: 29692608
[TBL] [Abstract][Full Text] [Related]
9. Periodontal health and serum, saliva matrix metalloproteinases in patients with mild chronic obstructive pulmonary disease.
Yıldırım E; Kormi I; Başoğlu ÖK; Gürgün A; Kaval B; Sorsa T; Buduneli N
J Periodontal Res; 2013 Jun; 48(3):269-75. PubMed ID: 22967248
[TBL] [Abstract][Full Text] [Related]
10. [Effects of shuxuening injection on the levels of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in acute exacerbated chronic obstructive pulmonary disease patients].
Wang TJ; Xie ZH; Zhao ZZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):191-4. PubMed ID: 22574591
[TBL] [Abstract][Full Text] [Related]
11. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
Bolton CE; Stone MD; Edwards PH; Duckers JM; Evans WD; Shale DJ
Chron Respir Dis; 2009; 6(2):81-7. PubMed ID: 19411568
[TBL] [Abstract][Full Text] [Related]
12. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
13. Enhanced exhalation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with COPD exacerbation: a prospective study.
Kwiatkowska S; Noweta K; Zieba M; Nowak D; Bialasiewicz P
Respiration; 2012; 84(3):231-41. PubMed ID: 22832426
[TBL] [Abstract][Full Text] [Related]
14. Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients.
Higashimoto Y; Yamagata Y; Iwata T; Okada M; Ishiguchi T; Sato H; Masuda M; Itoh H
Eur Respir J; 2005 May; 25(5):885-90. PubMed ID: 15863647
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of matrix metalloproteinase-9, tissue inhibitors of metalloproteinase-1 and their ratio are associated with impaired lung function in the elderly: a population-based study.
Olafsdóttir IS; Janson C; Lind L; Hulthe J; Gunnbjörnsdóttir M; Sundström J
Respirology; 2010 Apr; 15(3):530-5. PubMed ID: 20337997
[TBL] [Abstract][Full Text] [Related]
16. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Beeh KM; Beier J; Kornmann O; Buhl R
Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
[TBL] [Abstract][Full Text] [Related]
17. Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection.
Papakonstantinou E; Karakiulakis G; Batzios S; Savic S; Roth M; Tamm M; Stolz D
Respir Res; 2015 Jun; 16(1):78. PubMed ID: 26126526
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.
Lorente L; Martín MM; Labarta L; Díaz C; Solé-Violán J; Blanquer J; Orbe J; Rodríguez JA; Jiménez A; Borreguero-León JM; Belmonte F; Medina JC; Llimiñana MC; Ferrer-Agüero JM; Ferreres J; Mora ML; Lubillo S; Sánchez M; Barrios Y; Sierra A; Páramo JA
Crit Care; 2009; 13(5):R158. PubMed ID: 19799791
[TBL] [Abstract][Full Text] [Related]
19. [Markers of airway remodeling in induced sputum from healthy smokers].
Avilés B; Belda J; Margarit G; Bellido-Casado J; Martínez-Brú C; Casan P
Arch Bronconeumol; 2006 May; 42(5):235-40. PubMed ID: 16740239
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema.
Mao JT; Tashkin DP; Belloni PN; Baileyhealy I; Baratelli F; Roth MD
Chest; 2003 Nov; 124(5):1724-32. PubMed ID: 14605041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
